Is HYPERION DEFI, INC. (HYPD) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 42.7% / 30% | 8.1% / 30% | 1.2% / 30% | 443.04% / 5% | ✗ NOT HALAL |
| DJIM | 42.7% / 33% | 8.1% / 33% | 1.2% / 33% | 443.04% / 5% | ✗ NOT HALAL |
| MSCI | 306.5% / 33% | 57.8% / 33% | 8.5% / 33% | 443.04% / 5% | ✗ NOT HALAL |
| S&P | 42.7% / 33% | 8.1% / 33% | 1.2% / 33% | 443.04% / 5% | ✗ NOT HALAL |
| FTSE | 306.5% / 33% | 57.8% / 33% | 8.5% / 50% | 443.04% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 12.9% | |
| Operating Margin | -3690.9% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -324.1% | |
| Return on Assets (ROA) | -42.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$30M |
| Free Cash Flow | -$30M |
| Total Debt | $11M |
| Debt-to-Equity | 20.7 |
| Current Ratio | 2.7 |
| Total Assets | $4M |
Price & Trading
| Last Close | $3.49 |
| 50-Day MA | $3.45 |
| 200-Day MA | $6.23 |
| Avg Volume | 378K |
| Beta | 2.8 |
|
52-Week Range
$0.85
| |
About HYPERION DEFI, INC. (HYPD)
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in New York, New York.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is HYPERION DEFI, INC. (HYPD) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), HYPERION DEFI, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is HYPERION DEFI, INC.'s debt ratio?
HYPERION DEFI, INC.'s debt ratio is 42.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 306.5%.
What are HYPERION DEFI, INC.'s key financial metrics?
HYPERION DEFI, INC. has a market capitalization of $29M, and revenue of $57,336. Return on equity stands at -324.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.